{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-261601","form_type":"8-K","ticker":"DD","cik":"0001666700","company_name":"DuPont de Nemours, Inc.","filed_at":"2025-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.084428+00:00","generated_at":"2026-05-17T00:54:29.052263+00:00","sec_items":["1.01","2.01","5.02","7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"DuPont completes separation of Electronics into Qnity; board and management reshuffled; $4B debt reduction plan","bullets":["Completed spin-off of Electronics business as Qnity (Q); holders got 1 Q share per 2 DD shares.","Board reduced from 13 to 10; three directors resigned. Ed Breen stepped down as Executive Chairman, remains non-executive Chair.","Resigned: President of Electronics Jon Kemp and VP/Controller Michael Goss. Appointed: Bloemhard (Healthcare/Water), Ferreira (Diversified Industrials), Barber (CAO).","Special mandatory redemption triggered on $1.42B of New Notes; DuPont launches consent solicitation and tender offer for up to $739M of 2048 Notes.","DuPont expects to repay ~$4.0B aggregate principal of senior notes post-separation with ~$168M total refinancing expenses."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-261601","json":"https://secwatch.observer/filing/0001193125-25-261601.json","markdown":"https://secwatch.observer/filing/0001193125-25-261601.md","text":"https://secwatch.observer/filing/0001193125-25-261601.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1666700/000119312525261601/0001193125-25-261601-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1666700/000119312525261601/d70409d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:54:29.052263+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d09cb4a1825018e82a3a7847ecbd1b070093d7e0","claim":"DuPont de Nemours, Inc. completed a disposition involving Qnity Electronics, Inc. for pro rata dividend in-kind of all issued and outstanding shares of Qnity common stock (closed 2025-11-01).","evidence_excerpt":"On November 1, 2025, the Company effected the Distribution and completed the Separation.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1666700/000119312525261601/0001193125-25-261601-index.htm","confidence":0.95}],"comparable_filings":[{"accession":"0001104659-26-039924","ticker":"VREOF","company_name":"Vireo Growth Inc.","filed_at":"2026-04-06T23:59:59+00:00","headline":"Vireo closes Eaze acquisition for $47M in stock; CEO awarded performance-based RSUs up to 3.5% diluted","event_type":"m_and_a","sec_items":["1.01","2.01","3.02","5.02","7.01","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 5.02, 7.01, 8.01, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-039924","json":"https://secwatch.observer/filing/0001104659-26-039924.json","markdown":"https://secwatch.observer/filing/0001104659-26-039924.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1771706/000110465926039924/0001104659-26-039924-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1771706/000110465926039924/tm2611166d1_8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"On November 1, 2025, the Company effected the Distribution and completed the Separation.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1666700/000119312525261601/0001193125-25-261601-index.htm","comparable_excerpt":"adjustment with respect to certain of the estimated items included\nin the Estimated Closing Merger Consideration. In general, the Estimated Closing Merger Consideration\nis US$47,040,000 in base consideration (the “Base Consideration”), adjusted for certain items as described in the definition\nof Estimated Closing Merger Consideration in the Merger Agreement,","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1771706/000110465926039924/0001104659-26-039924-index.htm"}},{"accession":"0001193125-26-251758","ticker":"OCFC","company_name":"OCEANFIRST FINANCIAL CORP","filed_at":"2026-06-01T21:19:28+00:00","headline":"OceanFirst closes acquisition of Flushing Financial; issues shares to Warburg Pincus","event_type":"m_and_a","sec_items":["1.01","3.02","2.01","2.03","3.03","5.02","5.03","7.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 5.02, 7.01, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251758","json":"https://secwatch.observer/filing/0001193125-26-251758.json","markdown":"https://secwatch.observer/filing/0001193125-26-251758.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1004702/000119312526251758/0001193125-26-251758-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1004702/000119312526251758/d145829d8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"On November 1, 2025, the Company effected the Distribution and completed the Separation.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1666700/000119312525261601/0001193125-25-261601-index.htm","comparable_excerpt":"of Flushing (“ Flushing Common Stock ”) issued and outstanding immediately prior to the Effective Time, subject to certain exceptions, was converted into the right to receive 0.85 of a share (the “ Exchange Ratio ”) of common stock, par value $0.01 per share, of OceanFirst (“ OceanFirst Common Stock ” and such consideration, the “ Merger Consideration ”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1004702/000119312526251758/0001193125-26-251758-index.htm"}},{"accession":"0001193125-26-213462","ticker":"EWCZ","company_name":"European Wax Center, Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"European Wax Center completes take-private by General Atlantic at $5.80/share; stock delisted","event_type":"m_and_a","sec_items":["1.01","1.02","2.01","2.03","3.01","3.03","5.02","5.03","5.01","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 5.02, 8.01, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-213462","json":"https://secwatch.observer/filing/0001193125-26-213462.json","markdown":"https://secwatch.observer/filing/0001193125-26-213462.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1856236/000119312526213462/0001193125-26-213462-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1856236/000119312526213462/d137291d8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"On November 1, 2025, the Company effected the Distribution and completed the Separation.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1666700/000119312525261601/0001193125-25-261601-index.htm","comparable_excerpt":"excluded shares pursuant to the terms of the Merger Agreement, was cancelled and extinguished and automatically converted into the right to receive an amount in cash equal to $5.80 per share of Class A Common Stock, without interest thereon (the “ Class A Per Share Price ”), (ii) each share of the Company’s Class B common stock, par value $0.00001 per share","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1856236/000119312526213462/0001193125-26-213462-index.htm"}},{"accession":"0001628280-26-032558","ticker":"APAD","company_name":"Enhanced Group Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"Enhanced Group completes de-SPAC merger with Enhanced Ltd; redemptions of $201.7M","event_type":"m_and_a","sec_items":["1.01","2.01","5.06","3.02","9.01","4.01","3.01","3.03","5.01","5.02","5.03","5.05","7.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 5.02, 7.01, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-032558","json":"https://secwatch.observer/filing/0001628280-26-032558.json","markdown":"https://secwatch.observer/filing/0001628280-26-032558.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1956439/000162828026032558/0001628280-26-032558-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1956439/000162828026032558/apadu-20260506.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"On November 1, 2025, the Company effected the Distribution and completed the Separation.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1666700/000119312525261601/0001193125-25-261601-index.htm","comparable_excerpt":"On May 7, 2026, as contemplated by the Business Combination Agreement and as described in the section titled “ The BCA Proposal ” beginning on pa ge 180 of the Proxy Statement/Prospectus, the Company, Enhanced and Merger Sub consummated the business combination contemplated by the Business Combination Agreement, whereby: • Merger Sub merged with and into Enhanced (the “First Merger”), with Enhanced surviving the merger as a wholly owned subsidiary of the Company;","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1956439/000162828026032558/0001628280-26-032558-index.htm"}},{"accession":"0001140361-26-018716","ticker":"GYRE","company_name":"GYRE THERAPEUTICS, INC.","filed_at":"2026-05-04T23:59:59+00:00","headline":"Gyre Therapeutics completes $300M all-stock acquisition of Cullgen; appoints Ying Luo as CEO","event_type":"m_and_a","sec_items":["2.01","5.03","1.01","3.02","3.03","5.02","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 5.02, 7.01, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-018716","json":"https://secwatch.observer/filing/0001140361-26-018716.json","markdown":"https://secwatch.observer/filing/0001140361-26-018716.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126018716/0001140361-26-018716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126018716/ef20072211_8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"On November 1, 2025, the Company effected the Distribution and completed the Separation.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1666700/000119312525261601/0001193125-25-261601-index.htm","comparable_excerpt":"Revenue Code of 1986, as\n amended. Under the terms of the Merger Agreement, the Company acquired Cullgen in an all-stock transaction that valued Cullgen at\n approximately $300 million. At the effective time of the Merger (the “Effective Time”), each then outstanding share of Cullgen capital stock (the “Cullgen Capital Stock”), excluding shares of Cullgen","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126018716/0001140361-26-018716-index.htm"}},{"accession":"0001437749-26-012942","ticker":"LSF","company_name":"Laird Superfood, Inc.","filed_at":"2026-04-21T23:59:59+00:00","headline":"Laird Superfood acquires Terrasoul for $48M cash plus $5M earnout; Nexus invests $60M in preferred stock","event_type":"m_and_a","sec_items":["1.01","2.01","3.02","5.02","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 5.02, 7.01, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-012942","json":"https://secwatch.observer/filing/0001437749-26-012942.json","markdown":"https://secwatch.observer/filing/0001437749-26-012942.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1650696/000143774926012942/0001437749-26-012942-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1650696/000143774926012942/lsf20260421_8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"On November 1, 2025, the Company effected the Distribution and completed the Separation.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1666700/000119312525261601/0001193125-25-261601-index.htm","comparable_excerpt":"Interests (as defined in the Terrasoul Acquisition Agreement) which constitute all of the issued and outstanding equity interests of Terrasoul, for a purchase price of (i) $48.0 million in cash, subject to customary purchase price adjustments, including adjustments for working capital, cash, debt and transaction expenses and (ii) potential earnout consideration","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1650696/000143774926012942/0001437749-26-012942-index.htm"}},{"accession":"0001104659-26-044028","ticker":"MGTX","company_name":"MeiraGTx Holdings plc","filed_at":"2026-04-16T23:59:59+00:00","headline":"MeiraGTx acquires bota-vec gene therapy from Janssen for XLRP treatment","event_type":"m_and_a","sec_items":["1.01","1.02","2.01","7.01","8.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 7.01, 8.01, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-044028","json":"https://secwatch.observer/filing/0001104659-26-044028.json","markdown":"https://secwatch.observer/filing/0001104659-26-044028.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1735438/000110465926044028/0001104659-26-044028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1735438/000110465926044028/mgtx-20260415x8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"On November 1, 2025, the Company effected the Distribution and completed the Separation.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1666700/000119312525261601/0001193125-25-261601-index.htm","comparable_excerpt":"to mutations in the RPGR gene (the “RPGR Product”), and other related assets as described in the Asset Purchase Agreement. Buyer agreed to pay an upfront cash purchase price of $25,000,000 to Seller. Additionally, pursuant to and subject to the terms and conditions set forth in the Asset Purchase Agreement, Buyer agreed to pay Seller a one-time, future contingent","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1735438/000110465926044028/0001104659-26-044028-index.htm"}},{"accession":"0001140361-26-014610","ticker":"HRZN","company_name":"Horizon Technology Finance Corp","filed_at":"2026-04-14T23:59:59+00:00","headline":"Horizon Tech completes MRCC merger; issues 20.37M shares, receives $141.1M cash","event_type":"m_and_a","sec_items":["1.01","2.01","5.02","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 5.02, 7.01, 9.01","same event type: m_and_a","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-014610","json":"https://secwatch.observer/filing/0001140361-26-014610.json","markdown":"https://secwatch.observer/filing/0001140361-26-014610.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1487428/000114036126014610/0001140361-26-014610-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1487428/000114036126014610/ef20070439_8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"On November 1, 2025, the Company effected the Distribution and completed the Separation.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1666700/000119312525261601/0001193125-25-261601-index.htm","comparable_excerpt":"On April 14, 2026, Horizon Technology Finance Corporation (the “Company”), a Delaware corporation, completed its previously announced acquisition of Monroe Capital Corporation (“MRCC”), a Maryland corporation, pursuant to that certain Agreement and Plan of Merger, dated August 7, 2025","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1487428/000114036126014610/0001140361-26-014610-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}